Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
Global Endocrine Testing Market Fastest Growth, Opportunities Analysis And Forecast To 2029 | Abbott Laboratories, AdnaGen and Beckman Coulter/Danaher
eturbonews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eturbonews.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ALBANY, N.Y., Jan. 18, 2021 /PRNewswire/ Diseases of endocrine system involving hormones are fairly extensive, and the endocrine testing market has been making continuous strides. The advances have been in relation to the accuracy of the assays and the growing awareness about the common symptoms of the disorders in global populations. Some of the most common ones are male and female infertility, hypothyroidism, and hyperthyroidism. Some of the key tests in demand are follicle stimulating hormone (FSH), Luteinizing Hormone (LH), estradiol, insulin, and thyroid-stimulating hormone (thyrotropin) (TSH).
The worldwide prevalence of thyroid disorders has spurred the demand for endocrine testing for TSH levels. Advances in medical care and health infrastructure will propel the endocrine testing market to clock CAGR of 6.4% from 2019 to 2027. The revenue is expected to climb to reach US$ 10.6 Bn by the period-end.